← Leaderboards
Annemieke Kavelaars
University Of Illinois At Urbana-Champaign
$4,801,428
Attributed
$9,222,768
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–20$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,222,768 · 5
By mechanism
R01$8,782,768 · 4
R21$440,000 · 1
Top collaborators
- Cobi J Heijnen13 shared
- Robert Dantzer10 shared
- Keith W. Kelley5 shared
- Michael J Galko2 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingInnovationIn VivoPeripheralPathway InteractionsInflammationInflammatoryCellsPainMouse ModelNeuroinflammationResponseChronic PainPreventBaseChronicNeuronsMolecularIn VitroCytokineBrainChemotherapyResolutionSignal Transduction
Grant awards (25)
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$403,504
R01 · FY2020 · NS · contact PI
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$366,766
R01 · FY2020 · CA · contact PI
Mesenchymal Stem Cells to Repair Chemobrain$389,989
R01 · FY2019 · CA
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2019 · NS · contact PI
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$355,763
R01 · FY2019 · CA · contact PI
An exploratory proposal to move select Drosophila nociception screen hits into mouse models$200,000
R21 · FY2019 · NS
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2018 · CA
Mesenchymal Stem Cells to Repair Chemobrain$378,550
R01 · FY2018 · CA
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2018 · NS · contact PI
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$366,766
R01 · FY2018 · CA · contact PI
An exploratory proposal to move select Drosophila nociception screen hits into mouse models$240,000
R21 · FY2018 · NS
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2017 · CA
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2017 · NS · contact PI
Mesenchymal Stem Cells to Repair Chemobrain$402,051
R01 · FY2016 · CA
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain$375,286
R01 · FY2016 · NS · contact PI
A Novel Neuroimmune Risk Factor for Comorbid Depression and Chronic Pain$426,336
R01 · FY2015 · NS · contact PI
A novel molecular switch regulating transition from acute to chronic pain.$345,625
R01 · FY2015 · NS · contact PI
A Novel Neuroimmune Risk Factor for Comorbid Depression and Chronic Pain$421,353
R01 · FY2014 · NS · contact PI
A novel molecular switch regulating transition from acute to chronic pain.$342,170
R01 · FY2014 · NS · contact PI
A Novel Neuroimmune Risk Factor for Comorbid Depression and Chronic Pain$410,021
R01 · FY2013 · NS · contact PI
A novel molecular switch regulating transition from acute to chronic pain.$333,529
R01 · FY2013 · NS · contact PI
A Novel Neuroimmune Risk Factor for Comorbid Depression and Chronic Pain$421,112
R01 · FY2012 · NS · contact PI
A novel molecular switch regulating transition from acute to chronic pain.$346,718
R01 · FY2012 · NS · contact PI
A Novel Neuroimmune Risk Factor for Comorbid Depression and Chronic Pain$420,550
R01 · FY2011 · NS · contact PI
A novel molecular switch regulating transition from acute to chronic pain.$346,719
R01 · FY2011 · NS · contact PI